Cencora, Inc. (LON:0HF3)
344.38
+4.66 (1.37%)
At close: Dec 19, 2025
Cencora Employees
Cencora had 51,000 employees as of September 30, 2025. The number of employees increased by 5,000 or 10.87% compared to the previous year.
Employees
51,000
Change (1Y)
5,000
Growth (1Y)
10.87%
Revenue / Employee
4.88M GBP
Profits / Employee
23.60K GBP
Market Cap
49.33B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 51,000 | 5,000 | 10.87% |
| Sep 30, 2024 | 46,000 | 0 | - |
| Sep 30, 2023 | 46,000 | 2,000 | 4.55% |
| Sep 30, 2022 | 44,000 | 2,000 | 4.76% |
| Sep 30, 2021 | 42,000 | 20,000 | 90.91% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Convatec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
| HUTCHMED (China) | 1,811 |
Cencora News
- 4 days ago - Cencora to take majority control of OneOncology to expand cancer services - Reuters
- 4 days ago - Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology - Business Wire
- 16 days ago - Cencora Enhances Global Pharmaceutical Logistics Services, Cold Chain Capabilities - Business Wire
- 17 days ago - Cencora, Inc. (COR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 17 days ago - Cencora, Inc. (COR) Presents at Evercore 8th Annual Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - Cencora: Earnings Visibility Driving Re-Rating Potential - Seeking Alpha
- 6 weeks ago - Cencora, Inc. (COR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Cencora to invest $1 billion on US drug distribution, posts upbeat 2026 forecast - Reuters